Skip to main content
Fig. 7 | Arthritis Research & Therapy

Fig. 7

From: Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis

Fig. 7

Correlation of IgA anti-MCV and Disease Activity Score 28 (DAS28) in IgA anti-MCV-positive patients. The difference (delta) of anti-MCV IgA titers (delta anti-MCV IgA) from baseline to 24 weeks after RTX treatment correlated moderately with a greater improvement of DAS28 (delta DAS28) in anti-MCV IgA-positive patients (n = 21) (r = 0.49)

Back to article page